This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Case Reports

. 1986 Jul 5;293(6538):38-9.

doi: 10.1136/bmj.293.6538.38.

Resolution of dyskinesia and the "on-off" phenomenon in thyrotoxic patients with Parkinson's disease after antithyroid treatment

T H Caradoc-Davies

PMID: 3089397
PMCID: PMC1340780
DOI: 10.1136/bmj.293.6538.38

Case Reports

Resolution of dyskinesia and the "on-off" phenomenon in thyrotoxic patients with Parkinson's disease after antithyroid treatment

T H Caradoc-Davies. Br Med J (Clin Res Ed). 1986.

. 1986 Jul 5;293(6538):38-9.

doi: 10.1136/bmj.293.6538.38.

Author

T H Caradoc-Davies

PMID: 3089397
PMCID: PMC1340780
DOI: 10.1136/bmj.293.6538.38

No abstract available

PubMed Disclaimer

Similar articles

Hyperthyroidism "masked" the levodopa response in newly diagnosed Parkinson's disease patients.
Prakash KM, Kek PC. Prakash KM, et al. Parkinsonism Relat Disord. 2010 Dec;16(10):691-2. doi: 10.1016/j.parkreldis.2010.07.009. Epub 2010 Aug 21. Parkinsonism Relat Disord. 2010. PMID: 20729126 No abstract available.
Factors predictive of the development of Levodopa-induced dyskinesia and wearing-off in Parkinson's disease.
Warren Olanow C, Kieburtz K, Rascol O, Poewe W, Schapira AH, Emre M, Nissinen H, Leinonen M, Stocchi F; Stalevo Reduction in Dyskinesia Evaluation in Parkinson's Disease (STRIDE-PD) Investigators. Warren Olanow C, et al. Mov Disord. 2013 Jul;28(8):1064-71. doi: 10.1002/mds.25364. Epub 2013 Apr 29. Mov Disord. 2013. PMID: 23630119 Clinical Trial.
Unexpected improvement in levodopa-induced dyskinesia and on-off phenomena after introduction of memantine for treatment of Parkinson's disease dementia.
Vidal EI, Fukushima FB, Valle AP, Villas Boas PJ. Vidal EI, et al. J Am Geriatr Soc. 2013 Jan;61(1):170-2. doi: 10.1111/jgs.12058. J Am Geriatr Soc. 2013. PMID: 23311565 No abstract available.
Rating scales for dyskinesias in Parkinson's disease.
Goetz CG. Goetz CG. Mov Disord. 1999;14 Suppl 1:48-53. Mov Disord. 1999. PMID: 10493403 Review. No abstract available.
Motor complications of Parkinson's disease.
Martignoni E, Riboldazzi G, Calandrella D, Riva N. Martignoni E, et al. Neurol Sci. 2003 May;24 Suppl 1:S27-9. doi: 10.1007/s100720300033. Neurol Sci. 2003. PMID: 12774208 Review.

See all similar articles

Cited by

Thyroid Disorders and Movement Disorders-A Systematic Review.
Schneider SA, Tschaidse L, Reisch N. Schneider SA, et al. Mov Disord Clin Pract. 2023 Feb 3;10(3):360-368. doi: 10.1002/mdc3.13656. eCollection 2023 Mar. Mov Disord Clin Pract. 2023. PMID: 36949803 Free PMC article. Review.
Levodopa-induced dyskinesia is associated with increased thyrotropin releasing hormone in the dorsal striatum of hemi-parkinsonian rats.
Cantuti-Castelvetri I, Hernandez LF, Keller-McGandy CE, Kett LR, Landy A, Hollingsworth ZR, Saka E, Crittenden JR, Nillni EA, Young AB, Standaert DG, Graybiel AM. Cantuti-Castelvetri I, et al. PLoS One. 2010 Nov 10;5(11):e13861. doi: 10.1371/journal.pone.0013861. PLoS One. 2010. PMID: 21085660 Free PMC article.
Thyroid hormone level is associated with motor symptoms in de novo Parkinson's disease.
Umehara T, Matsuno H, Toyoda C, Oka H. Umehara T, et al. J Neurol. 2015 Jul;262(7):1762-8. doi: 10.1007/s00415-015-7780-x. Epub 2015 May 19. J Neurol. 2015. PMID: 25987207
Ultrasensitive TSH assay and anti-parkinsonian treatment with levodopa.
Vergès B, Giroud M, Vaillant G, Verges-Patois B, Brun JM, Putelat R. Vergès B, et al. J Neurol Neurosurg Psychiatry. 1992 Dec;55(12):1210-1. doi: 10.1136/jnnp.55.12.1210-a. J Neurol Neurosurg Psychiatry. 1992. PMID: 1479407 Free PMC article. No abstract available.
Graves' disease presenting as hemiparkinsonism.
Davies JS, Morrish PK, Scanlon MF. Davies JS, et al. J Endocrinol Invest. 2001 Mar;24(3):188-9. doi: 10.1007/BF03343841. J Endocrinol Invest. 2001. PMID: 11314749 No abstract available.

References

1. Age Ageing. 1973 May;2(2):92-101 - PubMed
1. Medicine (Baltimore). 1974 May;53(3):161-81 - PubMed
1. Endocrinology. 1974 Oct;95(4):1189-92 - PubMed
1. Eur Neurol. 1974;12(1):20-7 - PubMed
1. J Clin Endocrinol Metab. 1972 Jul;35(1):182-5 - PubMed

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions

LinkOut - more resources

Full Text Sources
- Europe PubMed Central
- PubMed Central
Medical
- MedlinePlus Health Information